Immix Biopharma, Inc. IMMX Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Immix Biopharma, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The official record: Immix Biopharma, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immix Biopharma, Inc.'s investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immix Biopharma, Inc.'s investing cash flow?
- Immix Biopharma, Inc. (IMMX) reported investing cash flow of -$4.8M in Q1 2026.
- How has Immix Biopharma, Inc.'s investing cash flow changed year-over-year?
- Immix Biopharma, Inc.'s investing cash flow decreased by 6990.0% year-over-year, from -$67.71K to -$4.8M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.